Zobrazeno 1 - 10
of 255
pro vyhledávání: '"M Beauduin"'
Publikováno v:
Anti-Cancer Drugs. 11:549-554
In a randomized trial, the authors evaluated the possible adjuvant activity of intraportal chemotherapy (with 5-fluorouracil 500 mg/m2/day in continuous infusion for 7 days and mitomycin C 10 mg/m2 at day 7) administered after surgery to half of the
Publikováno v:
Immuno-analyse & Biologie Spécialisée. 13:136-140
resume Les donnees cliniques, biologiques, scintigraphiques ( 99m Tc 123 I 201 TI) et histologiques ont ete examinees chez 90 patient(e)s opere(e)s, porteurs d'adenomes autonomes (nodules chauds). La correlation des parametres etudies permet d'identi
Autor:
Krasniqi, Eriseld1 (AUTHOR) eriseld.krasniqi@ifo.it, Ercolani, Cristiana2 (AUTHOR) cristiana.ercolani@ifo.it, Di Benedetto, Anna2 (AUTHOR) anna.dibenedetto@ifo.it, Di Lisa, Francesca Sofia1 (AUTHOR) francescasofia.dilisa@ifo.it, Filomeno, Lorena1 (AUTHOR) lorena.filomeno@ifo.it, Arcuri, Teresa1,3 (AUTHOR) patrizia.vici@ifo.it, Botti, Claudio4 (AUTHOR) claudio.botti@ifo.it, Pelle, Fabio4 (AUTHOR) fabio.pelle@ifo.it, Cavicchi, Flavia4 (AUTHOR) flavia.cavicchi@ifo.it, Cappelli, Sonia4 (AUTHOR) sonia.cappelli@ifo.it, Barba, Maddalena5 (AUTHOR) maddalena.barba@gmail.com, Pizzuti, Laura5 (AUTHOR) laura.pizzuti@ifo.it, Maugeri-Saccà, Marcello6,7 (AUTHOR) marcello.maugerisacca@ifo.it, Moscetti, Luca8 (AUTHOR) moscetti.luca@aou.mo.it, Grassadonia, Antonino9 (AUTHOR) grassa@unich.it, Tinari, Nicola10 (AUTHOR) ntinari@unich.it, Sanguineti, Giuseppe11 (AUTHOR) giuseppe.sanguineti@ifo.it, Takanen, Silvia11 (AUTHOR) silvia.takanen@ifo.it, Fragnito, Davide12 (AUTHOR) lorena.filomeno@ifo.it, Terrenato, Irene6 (AUTHOR) irene.terrenato@ifo.it
Publikováno v:
Cancers. Aug2024, Vol. 16 Issue 15, p2628. 20p.
Autor:
Nicole Delvaux, M Piccart, M P Derde, Christine Farvacques, M Beauduin, F De Brier, C Van Heer, Darius Razavi, L Kaufman
Publikováno v:
Journal of Clinical Oncology. 11:1384-1390
PURPOSE AND METHODS Although a high prevalence of adjustment disorders and anticipatory nausea secondary to adjuvant chemotherapy (CT) has been reported, little has been done to develop strategies to prevent these problems. A double-blind, placebo-co
Publikováno v:
Radiation Protection Dosimetry. 44:41-44
Publikováno v:
Radiation Protection Dosimetry. 31:437-442
Microdosimetric measurements (0.5 inch TEPC, 2 µm simulated diameter) were performed in similar conditions for 14 neutron beams with energies ranging from p(4)+Be to p(65)+Be used for radiobiology and therapy. They were collected in an intercomparis
Autor:
C. Pirson, F. Dessy, L. Gilbeau, J. Rosier, M.T. Hoornaert, H. Rooijackkers, A. Doneux, L. Harzee, C. Mitine, M. Beauduin
Purpose: To study the interobserver variability of base of skull meningiomas delineation on computed tomography. Methods and Materials: A group of eight physicians working in the same institution (two neurosurgeons, two neuroradiologists, two radiati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bd002808c3cdd2fd7848b6c7a77b15a5
https://doi.org/10.1159/000093726
https://doi.org/10.1159/000093726
Autor:
C, Focan, M P, Graas, M, Beauduin, J L, Canon, J P, Salmon, G, Jerusalem, D, Focan-Henrard, J P, Lobelle, D, Schallier
Publikováno v:
Anticancer research. 25(2B)
Forty-six previously untreated patients with advanced breast cancer were eligible for the present randomised phase I study. It aimed to evaluate the toxicity and activity of a therapeutic sequence with epirubicin on day 1 followed by paclitaxel on da
Autor:
M, Beauduin, J M, Deneufbourg, W, De Neve, J, Hermans, M T, Hoornaert, P, Scalliet, P, Spaas, J, Vanderick, M, Van Dijcke, P, Van Houtte, S, Vynckier, C, Weltens
Publikováno v:
Acta gastro-enterologica Belgica. 67(1)
Autor:
L Kayitalire, V Moreau, D Belpomme, M Beauduin, I Krakowski, J Janssens, Thierry Petit, J.L Canon, A De Pauw, S Gauthier
Publikováno v:
Gynecologic oncology. 91(1)
Objective This phase II study was performed to evaluate the activity and toxicity of gemcitabine plus cisplatin as first-line treatment of advanced epithelial ovarian cancer. Methods Chemonaive patients with histologically or cytologically confirmed